263 related articles for article (PubMed ID: 11560859)
1. 17beta-estradiol attenuates the development of pressure-overload hypertrophy.
van Eickels M; Grohé C; Cleutjens JP; Janssen BJ; Wellens HJ; Doevendans PA
Circulation; 2001 Sep; 104(12):1419-23. PubMed ID: 11560859
[TBL] [Abstract][Full Text] [Related]
2. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
Izumi Y; Kim S; Zhan Y; Namba M; Yasumoto H; Iwao H
Hypertension; 2000 Oct; 36(4):511-6. PubMed ID: 11040228
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.
Babiker FA; Lips D; Meyer R; Delvaux E; Zandberg P; Janssen B; van Eys G; Grohé C; Doevendans PA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1524-30. PubMed ID: 16627800
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
5. Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload.
Esposito G; Perrino C; Schiattarella GG; Belardo L; di Pietro E; Franzone A; Capretti G; Gargiulo G; Pironti G; Cannavo A; Sannino A; Izzo R; Chiariello M
Hypertension; 2010 Jan; 55(1):137-43. PubMed ID: 19901160
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
7. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.
Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA
Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652
[TBL] [Abstract][Full Text] [Related]
8. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
9. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy.
Rapacciuolo A; Esposito G; Caron K; Mao L; Thomas SA; Rockman HA
J Am Coll Cardiol; 2001 Sep; 38(3):876-82. PubMed ID: 11527648
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
12. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.
Patten RD; Pourati I; Aronovitz MJ; Alsheikh-Ali A; Eder S; Force T; Mendelsohn ME; Karas RH
J Card Fail; 2008 Apr; 14(3):245-53. PubMed ID: 18381189
[TBL] [Abstract][Full Text] [Related]
13. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
14. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
15. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
[TBL] [Abstract][Full Text] [Related]
16. Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
Ogita H; Node K; Liao Y; Ishikura F; Beppu S; Asanuma H; Sanada S; Takashima S; Minamino T; Hori M; Kitakaze M
Hypertension; 2004 Feb; 43(2):237-42. PubMed ID: 14676219
[TBL] [Abstract][Full Text] [Related]
17. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
[TBL] [Abstract][Full Text] [Related]
18. 17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats.
Shenoy V; Grobe JL; Qi Y; Ferreira AJ; Fraga-Silva RA; Collamat G; Bruce E; Katovich MJ
Peptides; 2009 Dec; 30(12):2309-15. PubMed ID: 19747516
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
